Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Effect of Octreotide on Plasma Lipid Metabolism in Acromegaly

Autor: Maria S. Corpas, Pedro Benito, A. Calañas, Ma. Galvez

Publikováno v: Annals of Pharmacotherapy. 28:1198-1198

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8f0f1608f1e11bd011cfd7530a611c7f
https://doi.org/10.1177/106002809402801014

Co-occurrence of mutations in NF1 and other susceptibility genes in pheochromocytoma and paraganglioma.

Autor: Mellid S; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Gil E; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Letón R; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Caleiras E; Histopathology Core Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Honrado E; Anatomical Pathology Service, Hospital of León, León, Spain., Richter S; Institute for Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Palacios N; Endocrinology Department, University Hospital Puerta de Hierro, Madrid, Spain., Lahera M; Endocrinology and Nutrition Department, La Princesa University Hospital, Madrid, Spain., Galofré JC; Department of Endocrinology, Clínica Universidad de Navarra, Pamplona, Spain., López-Fernández A; Hereditary Cancer Genetics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Calatayud M; Department of Endocrinology and Nutrition, Hospital Universitario 12 de Octubre, Madrid, Spain., Herrera-Martínez AD; Endocrinology and Nutrition Service, Reina Sofia University Hospital, Cordoba, Spain., Galvez MA; Endocrinology and Nutrition Service, Reina Sofia University Hospital, Cordoba, Spain., Matias-Guiu X; Department of Pathology, Bellvitge University Hospital, Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain., Balbín M; Molecular Oncology Laboratory, Instituto Universitario de Oncologia del Principado de Asturias, Hospital Universitario Central de Asturias, Oviedo, Spain., Korpershoek E; Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, Netherlands., Lim ES; Department of Endocrinology, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom., Maletta F; Pathology Unit , Department of Laboratory Medicine, Azienda Ospedaliero-Universitaria (AOU) Città della Salute e della Scienza di Torino, Torino, Italy., Lider S; Endocrinology Department, National Institute of Endocrinology, Bucharest, Romania., Fliedner SMJ; First Department of Medicine, University Medical Center Schleswig-Holstein, Lübeck, Germany., Bechmann N; Institute for Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Eisenhofer G; Institute for Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Department of Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Canu L; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Rapizzi E; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Bancos I; Division of Endocrinology, Metabolism and Nutrition, Mayo Clinic, Rochester, MN, United States., Robledo M; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain., Cascón A; Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.

Publikováno v: Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2023 Jan 25; Vol. 13, pp. 1070074. Date of Electronic Publication: 2023 Jan 25 (Print Publication: 2022).

Rab18 is reduced in pituitary tumors causing acromegaly and its overexpression reverts growth hormone hypersecretion.

Autor: Vazquez-Martinez R; Department of Cell Biology, Physiology, and Immunology, Campus de Rabanales. Edificio Severo Ochoa, University of Cordoba, Cordoba, Spain., Martinez-Fuentes AJ, Pulido MR, Jimenez-Reina L, Quintero A, Leal-Cerro A, Soto A, Webb SM, Sucunza N, Bartumeus F, Benito-Lopez P, Galvez-Moreno MA, Castaño JP, Malagon MM

Publikováno v: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2008 Jun; Vol. 93 (6), pp. 2269-76. Date of Electronic Publication: 2008 Mar 18.